Malcolm A. S. Moore

Malcolm A. S. Moore's AcademicInfluence.com Rankings

Malcolm A. S. Moore

Philosophy

#3432

World Rank

#5554

Historical Rank

Logic

#1157

World Rank

#1836

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Malcolm A. S. Moore's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Malcolm A. S. Moore Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Malcolm A. S. Moore's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. (2000) (2433)
Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth (2001) (1988)
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand (2002) (1846)
Evidence for circulating bone marrow-derived endothelial cells. (1998) (1797)
Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. (1986) (1265)
Ontogeny of the Haemopoietic System: Yolk Sac Origin of In Vivo and In Vitro Colony Forming Cells in the Developing Mouse Embryo * (1970) (1049)
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. (1980) (891)
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. (1997) (727)
Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells (2001) (717)
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment (2002) (678)
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. (1998) (669)
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice (2003) (668)
Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium (1988) (565)
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. (2001) (547)
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. (1985) (510)
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. (2000) (456)
Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity (1997) (418)
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. (1989) (408)
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates (1987) (390)
Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. (1987) (379)
In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. (1973) (365)
Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. (1991) (358)
Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. (1995) (349)
Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ Pathway (2006) (340)
Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural Mesothelioma (2012) (316)
Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. (1974) (314)
Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1 (2001) (300)
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias (2001) (285)
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. (1997) (281)
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. (1995) (273)
A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. (1969) (270)
Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. (2000) (265)
Role of stem cell migration in initiation of mouse foetal liver haemopoiesis (1975) (261)
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. (1981) (259)
Transendothelial Migration of Megakaryocytes in Response to Stromal Cell-derived Factor 1 (SDF-1) Enhances Platelet Formation (1998) (248)
Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. (1996) (242)
Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. (1978) (239)
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. (2006) (236)
A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. (2006) (228)
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase (2003) (224)
Generation of functional hemangioblasts from human embryonic stem cells (2007) (216)
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. (2002) (214)
Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. (1976) (212)
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. (1979) (197)
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion (1994) (196)
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. (1997) (192)
Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique. (1981) (189)
Nrf2 regulates haematopoietic stem cell function (2013) (184)
Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. (2000) (180)
Erythropoietin Derived by Chemical Synthesis (2013) (169)
Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells (1985) (169)
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. (2000) (167)
Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. (1980) (166)
Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation (2004) (163)
Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. (2007) (161)
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. (1989) (160)
Regulation of hematopoiesis by microvascular endothelium. (1997) (159)
Angiogenic Factors Reconstitute Hematopoiesis by Recruiting Stem Cells from Bone Marrow Microenvironment (2003) (150)
Modulation of hemopoiesis by prostaglandins. (1977) (148)
Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors. (2000) (146)
Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity (1982) (145)
The role of chemoattraction in cancer metastases. (2001) (144)
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. (2000) (143)
A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells. (2000) (142)
Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes (1984) (142)
Colony formation in vitro by myelomonocytic leukemic cells. (1969) (141)
The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. (2004) (139)
Regulation of megakaryopoiesis in long-term murine bone marrow cultures. (1978) (137)
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. (1983) (137)
In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells. (1973) (134)
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. (1997) (134)
Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. (1988) (134)
Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. (1985) (133)
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. (2004) (133)
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. (2003) (130)
Physical separation of colony stimulating cells from in vitro colony forming cells in hemopoietic tissue (1972) (123)
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. (1994) (118)
Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation (2004) (117)
Embryonic origin of the mouse macrophage. (1972) (116)
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. (2003) (114)
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. (1999) (114)
Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon. (1983) (113)
Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. (1992) (113)
Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. (1982) (112)
Cytogenetic analysis of human acute and chronic myeloid leukemic cells cloned in agar culture (1973) (112)
Activity of a Novel Anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against Human Lymphoma is Superior to Methotrexate and Correlates with Tumor RFC-1 Gene Expression (2003) (112)
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. (1996) (111)
Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. (1981) (106)
Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential (1993) (106)
Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity (2013) (106)
Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. (1995) (106)
Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2. (1984) (104)
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. (2013) (102)
Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. (1985) (101)
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent (1976) (100)
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. (2004) (99)
Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. (1988) (99)
The clinical use of colony stimulating factors. (1991) (99)
Tunneling Nanotubes (2012) (98)
Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera (1978) (98)
The fate of fetal and adult B-cell progenitors grafted into immunodeficient CBA/N mice (1979) (98)
Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells (2000) (95)
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. (1983) (95)
Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis. (1998) (93)
The Oncogene Nup98-HOXA9 Induces Gene Transcription in Myeloid Cells* (2004) (91)
Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. (1993) (91)
Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins. (1983) (90)
REGULATION OF HUMAN MYELOPOIESIS BY PROSTAGLANDIN E AND LACTOFERRIN (1981) (89)
Presence of tumour necrosis factor or a related factor in human basophil/mast cells. (1989) (88)
Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cells. (2014) (85)
Critical Role for Kit-mediated Src Kinase But Not PI 3-Kinase Signaling in Pro T and Pro B Cell Development (2004) (84)
Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells. (1977) (83)
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma. (2004) (83)
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. (1989) (82)
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. (1985) (82)
COLONY‐FORMING UNITS IN DIFFUSION CHAMBERS (CFU‐d) AND COLONY‐FORMING UNITS IN AGAR CULTURE (CFU‐c) OBTAINED FROM NORMAL HUMAN BONE MARROW: A POSSIBLE PARENT–PROGENY RELATIONSHIP (1979) (81)
High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. (1998) (81)
Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. (2004) (81)
Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes (2014) (80)
Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. (2012) (80)
Abnormal granulocyte feedback regulation of colony forming and colony stimulating activity-producing cells from patients with chronic myelogenous leukemia☆ (1977) (80)
High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. (1990) (80)
Converging pathways in leukemogenesis and stem cell self-renewal. (2005) (80)
Responsiveness of human granulocytic leukemic cells to colony-stimulating factor. (1974) (80)
Putting the neo into neoangiogenesis. (2002) (79)
Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing (2002) (78)
Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separation from WEHI-3 cell-conditioned medium. (1978) (77)
CUL‐4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein (2003) (76)
Ex vivo expansion of cord blood-derived stem cells and progenitors. (1994) (76)
Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells. (2008) (75)
Purification and partial characterization of a human hematopoietic precursor population. (1991) (75)
Regulation of Transendothelial Migration of Hematopoietic Progenitor Cells (1999) (74)
Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis. (2005) (74)
Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. (1987) (73)
Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation. (2006) (71)
Clinical use of recombinant human hematopoietic growth factors. (1989) (70)
Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. (1986) (69)
Smoking accelerates aging of the small airway epithelium (2014) (68)
At last: erythropoietin as a single glycoform. (2012) (67)
Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. (2000) (67)
Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. (1988) (67)
Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model (2016) (66)
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells (2004) (66)
Evidence for the clonal origin of chronic myeloid leukemia from a sex chromosome mosaic: clinical, cytogenetic, and marrow culture studies. (1974) (66)
Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. (2004) (65)
Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment. (1979) (65)
Optimization of Conditions for Ex Vivo Expansion of CD34' Cells From Patients With Stage IV Breast Cancer (1994) (65)
Evidence for a proliferative advantage of human leukemia colony-forming cells in vitro. (1978) (64)
Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E. (1982) (64)
Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis (2006) (64)
Characterization of colony-stimulating activity produced by human monocytes and phytohemagglutinin-stimulated lymphocytes. (1977) (64)
Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. (2007) (64)
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia (1978) (64)
Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis. (2006) (62)
Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog. (2010) (62)
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. (1980) (62)
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. (1997) (61)
OKT8 antibody inhibits OKT3-induced IL 2 production and proliferation in OKT8+ cells. (1983) (60)
Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice. (1979) (60)
Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes. (1982) (60)
Hematopoietic cells. (2006) (59)
Enforced Activation of STAT5A Facilitates the Generation of Embryonic Stem–Derived Hematopoietic Stem Cells That Contribute to Hematopoiesis In Vivo (2004) (59)
STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. (2005) (58)
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. (1982) (58)
Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? (1992) (58)
The acute monocytic leukemias: multidisciplinary studies in 45 patients. (1980) (58)
Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia. (1979) (56)
Induction of myeloid colony-stimulating activity in murine monocyte tumor cell lines by macrophage activators and in a T-cell line by concanavalin A. (1978) (55)
Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase (1978) (55)
In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression. (1996) (55)
Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. (2004) (54)
Role of interleukin-1 in hematopoiesis (1989) (54)
Adherence column and buoyant density separation of bone marrow stem cells and more differentiated cells (1971) (54)
Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells. (1986) (53)
Communication between white cells and the abnormalities of this in leukemia. (1978) (52)
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors (2011) (52)
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. (1993) (52)
Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA. (1999) (50)
Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. (1992) (50)
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses. (1995) (50)
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high‐dose chemotherapy plus granulocyte‐macrophage colony‐stimulating factor a randomized trial (1993) (49)
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. (2010) (49)
Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF. (1982) (49)
Pre‐clinical efficacy of PU‐H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma (2014) (49)
Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. (1985) (47)
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis. (1987) (47)
Diversity of human granulopoietic precursor cells: separation of cells that form colonies in diffusion chambers (CFU-d) from populations of colony-forming cells in vitro (CFU-c) by velocity sedimentation (1978) (45)
Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor. (1989) (45)
Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin (2011) (44)
Expansion of myeloid stem cells in culture. (1995) (44)
CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. (2015) (43)
Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase‐associated protein (1997) (43)
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. (1997) (42)
Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor. (1985) (41)
Cyclin C Regulates Human Hematopoietic Stem/Progenitor Cell Quiescence (2009) (41)
G‐CSF: Its relationship to leukemia differentiation‐inducing activity and other hemopoietic regulators (1982) (41)
Telomere dynamics in childhood leukemia and solid tumors: a follow-up study (2003) (41)
Cytokines and dexamethasone modulation of IL-1 receptors on human neutrophils in vitro. (1993) (41)
DEFECTS IN HEMATOPOIETIC DIFFERENTIATION IN NZB AND NZC MICE (1971) (41)
Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts. (2002) (40)
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination (1991) (40)
Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells. (2008) (40)
Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors (2004) (39)
Effect of recombinant murine tumor necrosis factor on hemopoietic reconstitution in sublethally irradiated mice. (1989) (39)
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment (2021) (38)
Commentary: the role of cell migration in the ontogeny of the lymphoid system. (2004) (37)
Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. (1981) (37)
The role of endothelium in the regulation of hematopoietic stem cell migration (1998) (37)
Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4. (2013) (37)
Role of Dimerization of the Membrane-associated Growth Factor Kit Ligand in Juxtacrine Signaling: The Sl 17H Mutation Affects Dimerization and Stability—Phenotypes in Hematopoiesis (1998) (36)
"Turning brain into blood"--clinical applications of stem-cell research in neurobiology and hematology. (1999) (36)
Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis. (1987) (35)
Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. (2005) (35)
The Regulatory Role of the Macrophage in Normal and Neoplastic Hemopoiesis (1977) (34)
Treatment of immunodeficiency with interleukin-2: initial exploration. (1984) (34)
An inhibitor of murine stem cell proliferation produced by normal human bone marrow. (1980) (33)
Prediction of relapse and remission in AML by marrow culture criteria. (1976) (33)
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia. (1978) (33)
Regulation of myelopoiesis in vitro: partial replacement of colony-stimulating factors by tumor-promoting phorbol esters. (1981) (33)
Suppression of spleen natural killing activity induced by BCG. (1980) (32)
Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes (2003) (32)
Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. (1994) (32)
Imaging Tunneling Membrane Tubes Elucidates Cell Communication in Tumors. (2017) (32)
Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E. (1986) (31)
Resistance to Bleomycin in Cancer Cell Lines Is Characterized by Prolonged Doubling Time, Reduced DNA Damage and Evasion of G2/M Arrest and Apoptosis (2013) (31)
Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells (1997) (31)
Radioprotection by murine and human tumor‐necrosis factor: Dose‐dependent effects on hematopoiesis in the mouse (1989) (31)
Effect of chloramphenicol and thiamphenicol on the in vitro colony-forming cell. (1974) (30)
Interleukin-2 correction of defectivein vitro T-cell mitogenesis in patients with common varied immunodeficiency (1984) (30)
Heterogeneity among resident murine peritoneal macrophages: separation and functional characterization of monocytoid cells producing granulocyte-macrophage colony-stimulating factor (GM-CSF) and responding to regulation by lactoferrin. (1981) (30)
Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). (1979) (30)
Total synthesis of glycosylated proteins. (2015) (30)
Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury (2016) (29)
Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells. (1987) (29)
Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes. (1998) (29)
Factors modifying stem cell proliferation of myelomonocytic leukemic cells in vitro and in vivo. (1970) (29)
Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil. (1990) (29)
Stem cell regulation in continuous hematopoietic cell culture. (1978) (29)
Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor (2012) (28)
Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment (2009) (28)
Modulation of granulocyte colony-stimulating factor receptors on murine peritoneal exudate macrophages by tumor necrosis factor-alpha. (1991) (28)
Marrow Culture—a New Approach to Classification of Leukemias (1975) (28)
Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy. (1990) (28)
The Paf oncogene is essential for hematopoietic stem cell function and development (2011) (28)
Tumor‐necrosis factor induces cell cycle arrest in multipotential hematopoietic stem cells: a possible radioprotective mechanism (1990) (27)
Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin. (1985) (27)
Stem cell proliferation: Ex vivo and in vivo observations (1997) (27)
IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies. (1991) (27)
Immunosuppression in aplastic anemia--postponing the inevitable? (1991) (27)
Ex vivo expansion and gene therapy using cord blood CD34+ cells. (1993) (26)
1,25-Dihydroxyvitamin D3 transcriptionally regulates tumour necrosis factor mRNA during HL-60 cell differentiation. (1988) (26)
Haemopoietic growth factor interactions: in vitro and in vivo preclinical evaluation. (1990) (26)
Modern Trends in Human Leukemia V (1983) (25)
Human B cell-inducing factor(s) for production of IgM, IgG and IgA: independence from IL 2. (1984) (25)
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1‐containing fusion proteins (2004) (25)
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene. (2004) (25)
Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. (1998) (24)
Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia. (1982) (24)
Colony stimulating and inhibiting activities in mouse serum after Corynebacterium parvum-endotoxin treatment. (1978) (24)
Tumor Necrosis Factor Alpha‐Stimulated Endothelium: An Inducer of Dendritic Cell Development from Hematopoietic Progenitors and Myeloid Leukemic Cells (2004) (24)
In vitro stimulation of phagocytosis in a macrophage cell line measured by a convenient radiolabeled latex bead assay. (1979) (24)
Hematopoietic reconstruction: new approaches. (1995) (23)
The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood. (1996) (23)
Age-Associated Changes in the Differentiation Potentials of Human Circulating Hematopoietic Progenitors to T- or NK-Lineage Cells (2013) (23)
B lymphocyte differentiation from fetal liver stem cells in89 Sr-treated mice1. (1975) (23)
AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer. (2014) (23)
Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand. (2002) (23)
Interleukin-11 expression in donor bone marrow cells improves hematological reconstitution in lethally irradiated recipient mice. (1994) (22)
Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy (1989) (22)
Tumours of the liver. (1996) (22)
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. (2015) (22)
Hematopoietic growth factors in cancer (1990) (22)
Generation of natural killer cell lines from murine long-term bone marrow cultures. (1985) (22)
Proliferation of Erythroid Colonies in Semi‐Solid Agar (1977) (22)
Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro. (2005) (22)
Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA (1997) (22)
Granulocyte colony‐stimulating factor‐induced activation of protein kinase‐C in myeloid cells (1997) (21)
Sodium azide enhancement of interleukin-2 production. (1983) (21)
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture. (2000) (21)
Second generation epothilones: Discovery of fludelone and its extraordinary antitumor properties (2005) (21)
Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins (1983) (21)
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. (1994) (21)
Synthesis of granulocyte–macrophage colony-stimulating factor as homogeneous glycoforms and early comparisons with yeast cell-derived material (2014) (20)
Sublethal Total Body Irradiation Causes Long-Term Deficits in Thymus Function by Reducing Lymphoid Progenitors (2017) (20)
Progress in the ex vivo expansion of hematopoietic progenitors. (1994) (20)
A cancer fate in the hands of a samurai (2010) (20)
UMG Lenti: Novel Lentiviral Vectors for Efficient Transgene- and Reporter Gene Expression in Human Early Hematopoietic Progenitors (2014) (20)
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. (1991) (19)
Benign Mesenchymal Stromal Cells in Human Sarcomas (2010) (19)
Long-term culture of human bone marrow macrophages: macrophage development is associated with the production of granulomonopoietic enhancing activity (GM-EA). (1985) (19)
Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders (1982) (19)
Macrophage-mediated cytostasis of neoplastic hemopoietic cells: cytofluorometric analysis of the reversible cell cycle block. (1978) (19)
Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies (1983) (19)
Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant. (1995) (19)
Biological characterization of a granulomonopoietic enhancing activity derived from cultured human lipid-containing macrophages. (1985) (18)
Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered expression of Ia antigens on effector and responding cells. (1985) (18)
Colony-forming B cells in F1 hybrid and transplanted CBA/N mice. (1978) (18)
Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells (2017) (18)
Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. (1985) (18)
Immuno‐electron microscopic tracing of lactoferrin, a regulator of myelopoiesis, into a subpopulation of human peripheral blood monocytes (1982) (18)
Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures. (1992) (17)
Maturation factors and cancer (1982) (17)
Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation. (1990) (17)
Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice. (1985) (17)
Expression of interleukin‐5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo (1997) (17)
Action of 1,25-(OH)2D3 in nude mice bearing transplantable human myelogenous leukemic cell lines. (1985) (17)
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes. (1983) (16)
Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors (2017) (16)
Methotrexate selection of long-term culture initiating cells following transduction of CD34+ cells with a retrovirus containing a mutated human dihydrofolate reductase gene (2002) (16)
OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells. (1985) (16)
Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and itsin vitro correction by interleukin 2 (1983) (16)
Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells. (2014) (16)
Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies. (1983) (16)
Interleukin-1 modulation of cytokine receptors on human neutrophils: in vitro and in vivo studies. (1993) (16)
Interleukin 3: An Overview (1988) (16)
Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells. (2006) (15)
Sequential Marrow Culture Studies and Terminal Deoxynucleotidyl Transferase Activities in Myelodysplastic Syndromes (1979) (15)
Umbilical cord blood: an expandable resource. (2000) (15)
Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides. (2015) (14)
Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells. (1983) (14)
Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study. (1994) (14)
Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA). (1988) (14)
Peripheral blood progenitor cell transplantation: where do we stand? Chairman's Summary of the European School of Oncology Task Force meeting Peripheral Blood progenitor cell's held September 29-30, 1995. (1996) (14)
Kit ligand cytoplasmic domain is essential for basolateral sorting in vivo and has roles in spermatogenesis and hematopoiesis. (2010) (14)
Assessing the role of the EGF receptor in the development and progression of pancreatic cancer (2014) (14)
Arecoline increases basic fibroblast growth factor but reduces expression of IL-1, IL-6, G-CSF and GM-CSF in human umbilical vein endothelium. (2015) (14)
Differences in the transmigration of different dendritic cells. (2006) (13)
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease (1980) (13)
Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta. (1994) (13)
Human interleukin 2 gene is located on chromosome 4. (1984) (13)
The future of cytokine combination therapy (1991) (13)
Regulation and function of hematopoietic stem cells. (1994) (13)
[Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis]. (1998) (13)
KIT Receptor Gain‐of‐Function in Hematopoiesis Enhances Stem Cell Self‐Renewal and Promotes Progenitor Cell Expansion (2013) (12)
Phenotypic evaluation of chronic myeloid leukemia. (1981) (12)
The AML 1-ETO fusion protein promotes the expansion of human hematopoietic stem cells (2001) (12)
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells. (1997) (12)
Therapeutic implications of serum factors inhibiting proliferation and inducing differentiation of myeloid leukemic cells. (1983) (12)
Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA (1998) (12)
Characterization of mast cell precursors by physical means: dissociation from T cells and T cell precursors. (1983) (12)
Pluripotential stem cell replication in continuous human, prosimian, and murine bone marrow culture. (1979) (12)
High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells. (2015) (11)
Density separation and characterisation of human blood leucocytes, including T and B lymphocytes. (1974) (11)
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. (1985) (11)
Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support. (2009) (11)
Diversity of human granulopoietic precursor cells: separation of cells that form colonies in diffusion chambers (CFU-d) from populations of colony-forming cells in vitro (CFU-c) by velocity sedimentation. (1978) (11)
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells. (1988) (11)
Tumor Necrosis Factor Alpha Enhances the Adenoviral Transduction of CD34+ Hematopoietic Progenitor Cells (2004) (10)
Granulocyte colony-stimulating factor modulation of cytokine receptors on murine bone marrow cells. In vivo and in vitro studies. (1991) (10)
Growth and responsiveness of human granulocytic leukemic cells in vitro. (1975) (10)
Induction of Proliferation and Differentiation of Leukaemic B Cells from Patients with Chronic Lymphocytic Leukaemia by Anti‐μ and Conditioned Medium (1987) (10)
A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cdk4/6. (2006) (10)
SAOS-2 Osteosarcoma Cells Bind Fibroblasts via ICAM-1 and This Is Increased by Tumour Necrosis Factor-α (2014) (10)
Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia. (1993) (9)
Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT) (1981) (9)
Production of presumptive humoral haematopoietic regulators in canine cyclic haematopoiesis (1982) (9)
Mast-cell growth factor: its role in mast-cell differentiation, proliferation, and maturation. (1985) (9)
Long-term bovine hematopoietic engraftment with clone-derived stem cells. (2005) (9)
The in vitro growth of murine high proliferative potential-colony forming cells is not enhanced by growth in a low oxygen atmosphere. (1992) (9)
Bond, H.M. et al. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood 103, 2062-2070 (2004) (9)
Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias. (1979) (9)
Successful treatment of diamond‐blackfan anemia with interleukin 3 (1993) (9)
Humoral regulation of granulopoiesis. (1979) (8)
Genetic and Functional Characterization of Isolated Stromal Cell Lines from the Aorta‐Gonado‐Mesonephros Region (2005) (8)
Myeloid leukemic cell differentiation induced by human postendotoxin serum and vitamin analogues. (1983) (8)
Linkage between Dendritic and T Cell Commitments in Human Circulating Hematopoietic Progenitors (2014) (8)
Extracellular vesicles from human airway basal cells respond to cigarette smoke extract and affect vascular endothelial cells (2021) (8)
T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis. (1981) (8)
Increased cell size, structural complexity and migration of cancer cells acquiring fibroblast organelles by cell-projection pumping (2019) (8)
Circulating Hematopoietic Stem and Progenitor Cells in Aging Atomic Bomb Survivors (2016) (8)
Waking up HSCs: a new role for E-selectin (2012) (8)
Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells. (2010) (8)
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models (2016) (7)
Ex vivo expansion of CD34+ hematopoietic progenitors. (1994) (7)
Characterization of a factor active on eosinophils and the red cell lineage. (1988) (7)
The use of hematopoietic growth and differentiation factors for bone marrow stimulation. (1988) (7)
Expression of DR antigens on early human progenitors of neutrophilic and eosinophilic colonies in diffusion chambers (CFUd). (2009) (7)
Density enrichment and characterization of hematopoietic progenitors and stem cells from umbilical cord blood. (1996) (7)
Normal and Leukemic Hematopoiesis in Diffusion Chambers: Comparison with In Vitro Culture Systems (1980) (7)
Hemopoietic Stem Cells During Embryonic Development and Growth (1976) (7)
Optimizing conditions for gene transfer into human hematopoietic cells. (1999) (7)
Regulatory role of macrophages in hemopoiesis. (1976) (7)
The Granulocytic and Monocytic Stem Cell (1976) (6)
Induction and long-term maintenance of Thy-1 positive T lymphocytes: derivation from continuous bone marrow cultures. (1980) (6)
Potential Hydrodynamic Cytoplasmic Transfer between Mammalian Cells: Cell-Projection Pumping. (2020) (6)
Interpretations of culture data in aplastic anemia: evidence for a suppressor cell involvement. (1979) (6)
Gene therapy--the challenge for the future. (1996) (6)
Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures. (1976) (6)
Physical Separation and Kinetics of Colony-forming Cells in Diffusion Chambers in Vivo (CFU-d) and Colony-forming Cells in Agar in Vitro (CFU-c) (1978) (5)
Inhibition of spontaneous proliferation of human leukemic B cells from patients with chronic lymphocytic leukemia by anti-mu antibodies. (1987) (5)
Regulatory interactions in normal and leukemic myelopoiesis. (1979) (5)
Effector Cell Functions in Long-Term Culture of Murine, Prosimian, and Human Bone Marrow (1980) (5)
Regulation of Myelopoiesis In Vitro: Partial Replacement of Colony-Stimulating Factors by Tumor-Promoting Phorbol Esters (1981) (5)
MATURATIONAL FACTORS IN MYELOID LEUKEMIA1 (1985) (5)
Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA. (1998) (5)
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias (2004) (5)
Proliferative effects of a recombinant human granulocyte colony-stimulating factor (rG-CSF) on highly enriched hematopoietic progenitor cells. (1987) (4)
Mast cell growth factor. (1983) (4)
The Ontogeny of the Hematopoietic System (2009) (4)
Protein tyrosine kinases in granulocyte colony stimulating factor receptor signal transduction, myeloid cell proliferation, and neutrophil activation. (1997) (4)
Biological activities of a human pluripotent hemopoietic colony-stimulating factor. (1985) (4)
In vitro culture studies in chronic granulocytic leukaemia. (1977) (4)
Biologicals for cancer treatment: growth and differentiating agents. (1986) (4)
Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia. (1992) (4)
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia. (1988) (4)
Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant Recipients. (2015) (4)
Coordinate Actions of Hematopoietic Growth Factors in Stimulation of Bone Marrow Function (1990) (4)
Targeting Cdk4/6 in combination therapy of chemoresistant multiple myeloma (2008) (4)
Proliferation and Differentiation Control Mechanisms in Myeloid Leukemia (1984) (4)
Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells. (1981) (3)
Pre-Clinical Evaluation of a Novel DNA Crosslinking Agent, Bo-1055 in B-Cell Lymphoma (2014) (3)
Genetic and oncogenic influences on myelopoiesis. (1981) (3)
Dendritic Cells Adenovirus Vector Expressing CD 40 Ligand and Naive Tumor Regression Induced by Intratumor Administration of Updated Version (2000) (3)
Relationship between spontaneous γH2AX foci formation and progenitor functions in circulating hematopoietic stem and progenitor cells among atomic-bomb survivors. (2016) (3)
Agar culture studies in CML and blastic transformation. (1975) (3)
Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT). (1981) (3)
Lymphokine factors inducing IgG production in human B-cell line ARH-77 and stimulatory effects of phorbol ester tumor promoter. (1983) (3)
Chapter Forty-Nine – Hematopoietic Stem Cells (2007) (3)
Granulocyte colony-stimulating factor activates protein kinase A in granulocytic but not monocytic precursors or neutrophils. (1998) (3)
G-CSF as a Differentiation-Inducing Agent in Normal and Leukemic Myelopoiesis (1987) (3)
Interactions between hematopoietic growth factors: the clinical role of combination biotherapy. (1989) (3)
NY-ESO-1 antigen expression as a prognostic factor for soft tissue sarcomas. (2017) (3)
Hematopoietic Stem Cells (2009) (3)
Colony-stimulating factors (1989) (3)
ACTIVITY OF MACROPHAGE CELL LINES IN SPONTANEOUS AND LPS, LYMPHOKINE OR ANTIBODY-DEPENDENT KILLING OF TUMOR TARGETS (1980) (3)
Graft-Vs-Graft Immune Interaction Is the Likely Mechanism of Absolute Unit Dominance in Double Unit Cord Blood (DCB) Transplantation Using Patient DCB Grafts: An in Vivo but Not in Vitro Phenomenon (2008) (3)
Myeloid and erythroid stem cells: regulation in normal and neoplastic states. (1984) (3)
Constitutive production and biochemical purification of leukemia differentiation factors by a human epithelial bladder carcinoma cell line (1984) (3)
Proliferation of leukemic B cells in response to SAC and anti-mu. Evidence for different modes of action and comparison to proliferation and differentiation induced by conditioned medium. (1988) (3)
Macrophage Regulatory Networks (1981) (3)
Macrophage Colony-Stimulating Factor (2020) (3)
Activity of PU-H71, a novel HSP90 inhibitor, and bortezomib in Ewing sarcoma preclinical models. (2013) (3)
Induction of sequential G1 arrest and synchronous S phase entry by reversible CDK4/CDK6 inhibition sensitizes myeloma cells for cytotoxic killing through loss of IRF-4. (2009) (3)
Interactions between Hematopoietic Growth Factors in Normal and Leukemic Stem Cell Differentiation a (1989) (3)
Cover Picture: At Last: Erythropoietin as a Single Glycoform (Angew. Chem. Int. Ed. 46/2012) (2012) (2)
In vitro purging with 4-hydroperoxycyclophosphamide and its effects on the hematopoietic and stromal elements of human bone marrow (1985) (2)
T-cell growth factor (Interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell lines (1981) (2)
Targeting Cdk4/6 in Combination Therapy Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma through Synergistic Mitochondria Depolarization. (2007) (2)
Cell-projection pumping: A hydrodynamic cell-stiffness dependent mechanism for cytoplasmic transfer between mammalian cells (2019) (2)
Hematopoietic Stem Cells: Proliferation, Purification, and Clinical Applications (2002) (2)
Determination of telomerase activity and telomere length. (2005) (2)
Loss of Heterozygosity (LOH) of the NUP98 Gene Is an Adverse Prognostic Factor in Acute Myeloid Leukemia (AML). (2006) (2)
Dyshematopoiesis in combined immune deficiency with congenital neutropenia (1994) (2)
(CFU-F) and their progeny Characterization of human bone marrow fibroblast colony-forming cells (2011) (1)
Clinical utility of bone marrow culture. (1976) (1)
[Production of a mastocyte growth factor in lymphocyte cultures stimulated by a mitogen or by allogenic cells]. (1980) (1)
Potential Hydrodynamic Cytoplasmic Transfer between Mammalian Cells: Cell-Projection Pumping. (2020) (1)
The “stem cell leukemia” gene: what's in a name? (2004) (1)
Regulation of Growth and Differentiation in Haemopoietic Colonies Growing in Agar (2008) (1)
Ex Vivo expansion Of Umbilical Cord Blood CD34+ Cells Under Hypoxic Conditions Using Novel Compound#999 With Cytokines (2013) (1)
Hematopoietic growth factor receptors (1989) (1)
of gastrointestinal stromal tumor (2012) (1)
Antileukemic Effects of Buthionine Sulfoximine (BSO) (NSC 326231) in Vivo: A Pilot Study in Acute Myeloblastic Leukemia (2001) (1)
The Nup98-HoxA9 Leukemogenic Fusion Protein Blocks Xpo1 and Tap-Mediated Nuclear Export (2011) (1)
Abstract 823: Water-soluble ureidomustine (BO-1055) potently suppresses orthotopic 22Rv/HL2 prostate tumor xenografts: early preclinical studies (2014) (1)
TECHNICAL WORKSHOP (1996) (1)
Early Hematopoietic Zinc Finger protein ( EHZF ) , the human homologue to mouse (2003) (1)
The LYL-1 oncoprotein is ubiquitously expressed in the mouse (2000) (1)
Novel Alkylating Agent, Ureidomustine Exhibit Pre-Clinical Efficacy in B-Cell Lymphoma with Minimal Dose-Limiting Myelotoxicity (2015) (1)
Correction: Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury (2018) (1)
Chapter 47 – Ontogeny of the Hematopoietic System (2013) (1)
Expression of myeloid differentiation antigens on myeloblasts in bone marrow of patients with myelodysplastic syndromes. (1987) (1)
Allogeneic T lymphocyte clones derived from rejected human kidney produce high levels of a new lymphokine active on murine interleukin 3-sensitive cell lines. (1987) (1)
G-Csf receptor-mediated up-regulation of c-fos but not c-raf mRNA expression in myeloid cells (2004) (1)
An Animal Model That Predicts Unit Engraftment in Double Unit Cord Blood Transplant Recipients. (2007) (1)
Cytokine Interactions in Hematopoiesis: An Introduction and Overview (1992) (1)
The use of colony stimulating factors in combination. (1991) (1)
Genetic and Functional Characterization of Isolated Stromal Cell Lines from the Aorta-Gonado-Mesonephros (AGM)-Region. (2004) (1)
Niche-Based Screening Identifies Novel Small Molecules That Overcome Stromal Effects in Multiple Myeloma (2012) (1)
Niche-Based Screening Reveals Leukemia Stem Cell Specific Therapeutics (2011) (1)
Abstract 4866: Enhanced adipogenesis of bone marrow-derived stromal cells by ovarian cancer cells via BMP4 and IL8 is associated with increase in cancer stem/progenitor cells and cancer cell proliferation (2014) (1)
Regulatory Defects in Leukemia: In Vitro Analysis (1985) (1)
mature and immature hematopoietic progenitor and stem cells derived factor-1 induces mobilization of - Plasma elevation of stromal cell (2013) (1)
Anti-Neoplastic Effect Of High Affinity and Covalent-Binding Microtubule Stabilizing Agents In AML Cells Sensitive and Resistant By ABC-Transporter Overexpression (2013) (0)
Abstract LB-256: Catena: A novel cellular entity composed of ovarian cancer stem cells (2010) (0)
Drug Screening of Primary Human Pediatric Pre-B Cell Acute Lymphoblastic Leukemia (pre-B ALL) Cells in Their Stromal Niche (2012) (0)
Comparative efficacy of bone marrow engraftment following high-dose carboplatin plus cyclophosphamide versus high-dose CBDCA/TAXOL , when rescued with Txl/cyclophosphamide and GCSF mobilized peripheral blood progenitor cells (1994) (0)
Hematopoietic stem cells and progenitor cells: their role in normal blood formation 1 (2014) (0)
Colony-stimulating factors. A panel discussion. (1989) (0)
Direct visualization of circulating sarcoma cells by whole-blood fluorescence in situ hybridization. (2010) (0)
hematopoietic and microenvironmental elements of human bone marrow Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the (2011) (0)
Purging in Murine Bone Marrow Expansion Cultures Differentiation Therapy as a Method of Leukemic Cell Ex Vivo (2007) (0)
Fludelone, an optimized epothilone for ovarian cancer treatment (2005) (0)
Telomerase Activity and Telomere Length in Acute and Chronic Leukemia , Pre-and Post-ex Vivo Culture 1 (2000) (0)
MACROPHAGE HETEROGENEITY: ROLE IN HEMOPOIESIS AND CYTOTOXICITY FOR NORMAL AND NEOPLASTIC TARGETS (1978) (0)
Introduction for Donald Metcalf (1987) (0)
ABUNDANT EXPRESSION OF ZINC FINGER PROTEIN 521 IN AMLS CORRELATES WITH SPECIFIC GENETIC ABERRATIONS AND CONTRIBUTES TO THE LEUKAEMIC PHENOTYPE IN AMLS WITH MLL REARRANGEMENTS (2012) (0)
Hematopoietic stem cells and progenitor cells: their role in normal blood formation - part 1 of 2 (2014) (0)
Diagnostic and Prognostic Significance of the CFU-c Assay in Acute Nonlymphoblastic Leukemia 1 (2006) (0)
Regulation of Hematopoietic Differentiation and Its Disruption Group Report (1985) (0)
Abstract 4814: Tunneling nanotubes facilitate intercellular communication and trafficking between mesothelioma cells (2010) (0)
Clearance receptor controls death and (2016) (0)
[Characterization of a factor produced by human alloreactive T lymphocyte clones, active on the eosinophils and precursors of erythroid strains]. (1987) (0)
Bone Marrow Progenitors That Are Expanded by c-kit-ligand and Yield Pure Dendrit ic Cell Colonies in the Presence o f Granulocyte / Macrophage Colony-st imulat ing Factor and Tumor Necrosis Factor c ~ By (2003) (0)
Increased Resistance and Selection in Paclitaxel for Peripheral Blood Progenitor Cells Following Transduction with the MDR1 Gene (2000) (0)
disease heterogeneity , cytogenetic status , and overall survival Telomerase and telomere length in multiple myeloma : correlations with (2003) (0)
Embryonic Origin of the Mouse Macrophage 842 Blood (2005) (0)
PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Bortezomib inhibits STAT 5-dependent degradation of LEF-1 , inducing granulocytic differentiation in congenital neutropenia CD 34 1 cells (2014) (0)
Abstract LB-250: Smoking reprograms human airway basal cells in vivo toward an embryonic stem cell-like molecular phenotype similar to that of lung adenocarcinoma (2010) (0)
Depletion of NUP98: A Common Leukemogenetic Mechanism in AML? (2005) (0)
Hematopoietic Progenitors Commitments in Human Circulating Linkage between Dendritic and T Cell (2014) (0)
Osteomyelofibrosis Mice : Insights into the Pathophysiology of Thrombopoietin cDNA in Immune-Compromised Adenovector-Mediated Expression of Human (1998) (0)
Abstract 4021: Transcriptomic landscape of Ewing sarcoma based on RNAseq. (2013) (0)
Abstract LB-62: Direct visualization of circulating sarcoma cells by whole-blood fluorescence in-situ hybridization (2010) (0)
L3MBTL1: A Polycomb Protein At the Node of Crosstalk Between the BMP4 and Hippo Signaling Pathways in Erythropoiesis. (2012) (0)
SERUM HEMATOPOIETIC INHIBITORS AND TUMOR NECROSIS FACTOR (1979) (0)
CUL-4A Short Hairpin RNA (shRNA) Impairs Normal Hematopoiesis of Human Cord Blood CD34+ Cells In Vitro and In Vivo. (2005) (0)
Abstract 18: Deep-sequencing of ovarian cancer stem cells (2011) (0)
Ubiquitin-Proteolytic Control of HOX Homeodomain Proteins. (2006) (0)
Low Density Mononuclear Cells from Umbilical Cord Blood as a Target for Retrovirally Mediated Gene Transfer. (1996) (0)
Hematopoietic stem cells and progenitor cells: their role in normal blood formation 2 (2014) (0)
lymphoma antagonist : in vitro and in vivo studies in multiple myeloma and Telomerase inhibition with an oligonucleotide telomerase template (2003) (0)
Selective protection of hematopoietic stem cells from chemotherapy (1992) (0)
TdT activity in B cell ALL. (1978) (0)
[Distribution of hematopoietic stem cells in the mononuclear fraction of human umbilical cord blood]. (1996) (0)
Human Cancer Biology Benign Mesenchymal Stromal Cells in Human Sarcomas (2010) (0)
A hydrodynamic mechanism for cytoplasmic transfer between mammalian cells: Cell-projection pumping (2019) (0)
Cytokine Regulation of Primitive Progenitors in Culture (2020) (0)
Constitutive Activation of STAT5a in Myeloid Progenitors of Severe Congenital Neutropenia Patients Leads to Downregulation of LEF-1. (2007) (0)
Clonal analysis of crisis in bone marrow endothelial cells transduced with human telomerase reverse transcriptase (hTERT). (2004) (0)
Intrinsic abnormalities in b cells and granulocyte precur- sors of autoimmune nzb mice. Abstr. (1979) (0)
SYNTHESIS AND RELEASE OF E R Y T H R O I D COLONY- AND BURST-POTENTIATING ACTIVITIES BY PURIFIED POPULATIONS OF M U R I N E PERITONEAL MACROPHAGES* (2003) (0)
Assay for Leukemia Differentiation Induction (2003) (0)
Abstract 1157: Ubiquitin-proteolytic control of HOX homeodomain proteins in normal and malignant hematopoiesis (2010) (0)
Abstract 2752: Novel inhibitor of HSP90- PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models. (2013) (0)
Chapter 47 – Hematopoietic Stem Cells (2014) (0)
Step-Wise Differentiation of CD34+ Cell Derived from Nuclear Transfer-Human Embryonic Stem Cells into Myeloid and Lymphoid Precursors. (2005) (0)
Selective Targeting of Leukemic Over Normal Stem Cells by the Serotonin Receptor Antagonist SB-216641 (2011) (0)
soybean agglutinin Depletion of stromal cell elements in human marrow grafts separated by (2011) (0)
chemotherapy- induced bone marrow suppression thrombopoietin cDNA maintains platelet levels during radiation-and In vivo adenovirus vector-mediated transfer of the human (2011) (0)
TdT activity in B cell ALL [letter] (1978) (0)
Identification of Small Molecules Selectively Targeting Leukemic Stem Cells within Their Stromal Niche (2012) (0)
Long-Term Coculture of Adult Human Healthy Donor CD34+ Cells Shows Elevation of Telomeres in a Subgroup of Donors Independent of Age, Stem Cell Function and Telomerase Activity. (2004) (0)
Telomere Length Plays No Role in Clinical Unit Dominance After Double-Unit Cord Blood Transplantation (2012) (0)
Derivation and Drug Screening of Growth Factors- and Stroma-Dependent Human Multiple Myeloma Cells (2012) (0)
Abstract 3980: Pre-clinical evaluation of a novel DNA crosslinking agent, Ureidomustin (BO-1055) in pediatric sarcomas (2014) (0)
Abstract C250: The pericyte as a novel stromal element and therapeutic target in sarcoma (2009) (0)
Aberrant Autocrine and Paracrine CD40L Signaling Promotes Primary Myeloma Cell Survival and Attenuates Bortezomib-Induced Apoptosis. (2005) (0)
Abstract LB-97: Identification of a novel splice variant of Hyaluronan Synthase-2 (HAS2) in ovarian cancer stem cells (2011) (0)
Abstract LB-98: Transcriptomic and genomic landscape of ovarian cancer stem cells (2012) (0)
In Vitro Culture Reveals Microenvironment-Dependent Growth, Heterogeneity and Hierarchical Structure of Primary Human Pediatric Pre-B Cell Acute Lymphoblastic Leukemia (pre-B ALL) Cells (2011) (0)
Functionally distinct stages in B-lymphocyte maturation. (1977) (0)
α hematopoietic stem/progenitor cells involves downmodulation of C/EBP STAT5-induced self-renewal and impaired myelopoiesis of human (2013) (0)
REGULATORY ROLE OF MACROPHAGES IN NORMAL AND NEOPLASTIC HEMOPOIESIS (1979) (0)
Enforced Expression of BMI-1 in Postnatal Human CD34+ Cells Promotes Erythroid Differentiation (2007) (0)
Abstract 1625: Ureidomustine, a novel DNA-crosslinking agent shows activity in sarcoma preclinical models and lacks toxicity in normal tissues (2015) (0)
Immunodeficient cba/n mice. (1979) (0)
Airway Basal Cells Of Healthy Smokers And Human Lung Adenocarcinomas Share A Common Embryonic Stem Cell-like Transcriptional Program (2010) (0)
The telomerase template antagonist GRN163L reduces tumor volume in a multiple myeloma xenograft model (2005) (0)
NK-Lineage Cells Circulating Hematopoietic Progenitors to T-Differentiation Potentials of Human Age-Associated Changes in the Brink and Yoichiro Kusunoki (2013) (0)
Monocytes Modulate Megakaryocyte-Mediated Fibrosis of Bone Marrow Stromal Cells in Vitro (2012) (0)
Anti-Apoptotic Bcl2 and Bcl-Xl Proteins Involved in Stroma-Induced Drug Tolerance to Hsp70 and Hsp90 Inhibitors in Leukemia and B-Cell Lymphoma (2012) (0)
Corrigendum to "Relationship between spontaneous γH2AX foci formation and progenitor functions in circulating hematopoietic stem and progenitor cells among atomic-bomb survivors" [Mutat. Res. - Genet. Toxicol. Environ. Mutagen. 802 (2016) 59-65]. (2017) (0)
Response to an Active Vitamin D3 Metabolite of Transplantable Human Myeloid Leukemic Cell Lines in Adult Nude Mice (1986) (0)
Cytokine networks in congenital, idiopathic and iatrogenic neutropenia (1989) (0)
Myeloprotective Effects of Interleukin-1 Following Exposure to Chemoradiotherapy (1990) (0)
Protection of Marrow from Methotrexate Toxicity by Gene Transfer of Mutant Forms of Dihydrofolate Reductase into Hematopoietic Progenitor Cells (1998) (0)
Maturation Factors in Cancer (Progress in Cancer Research and Therapy, vol. 23) (1984) (0)
Abstract LB-206: A new platform for diagnosis and therapeutic targeting of cancer stem cells (2012) (0)
ZINC FINGER PROTEIN 521 (EHZF/ZNF521) ANTAGONIZES EARLY B-CELL FACTOR 1 AND MODULATES THE B-LYMPHOID DIFFERENTIATION OF PRIMARY HEMATOPOIETIC PROGENITORS (2011) (0)
Abstract 1376: Identification of selective inhibitors of ovarian cancer stem cells by high-throughput screening (2011) (0)
the regulation of cell proliferation by prostaglandin E with granulocyte-macrophage colony-forming cells (CFU-GM) is associated Expression of Ia-antigens on normal and chronic myeloid leukemic human (2011) (0)
Cloning of murine b lymphocytes in semisolid culture. Growth requirements and sensitivity to anti-immunoglobulin (ig). Abstr. (1976) (0)
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor ( protein purfcation / heatopoietlc sem cells ) (2003) (0)
Procede de developpement ex vivo de cellules parentes hematopoietiques (1995) (0)
The Telomerase Template Antagonist GRN163L in Combination with Chemotherapeutics Reduces Tumor Volume in Multiple Myeloma Xenograft Models. (2005) (0)
probable pluripotential stem cells Continuous human bone marrow culture: Ia antigen characterization of (2011) (0)
Identification and Characterization of Hematopoietic Stem (HSC)/Progenitor Cells in Human Solid Tumors (2008) (0)
Bortezomib Induces Granulocytic Differentiation of CD34 Cells from Congenital Neutropenia Patients by Reversing Hyperactivate-STAT5a- Dependent Downregulation of LEF-1 (2014) (0)
TIF1γ Knockdown Enhances Hematopoietic Stem Cell Self Renewal with Preferential Myeloid Differentiation and Delayed Erythropoiesis (2011) (0)
Abstract 3887: Reversible inhibition of CDK4/CDK6 sensitizes hematological tumor cells for cytotoxic killing by inducing sequential G1 arrest and synchronous S phase entry that enhances the intrinsic apoptosis pathway (2010) (0)
Analysis of liver preneoplastic lesions (0)
Early haematopoietic zinc finger protein/zinc finger protein 521 (2008) (0)
CD34+ hematopoietic cells using a single genetic element Maintaining the self-renewal and differentiation potential of human (2013) (0)
Abstract 211: Ubiquitin-proteolytic regulation of hematopoietic stem cell expansion (2012) (0)
A Novel in Vitro Model of Focal Fibrosis in Bone Marrow Stromal Co-Culture of CD34+ Cells From Patients with Idiopathic Myelofibrosis. (2009) (0)
megakaryocytic progenitors long-term proliferation and differentiation of myeloid and Human bone marrow microvascular endothelial cells support (2011) (0)
The relationship between multipotential stem cells (cfu-s) and early b lymphocytes. Abstr. (1978) (0)
The role of factors in differentiation of non-erythroid cells. (1978) (0)
Temporal Generation and Molecular Characterization of Functional Hematopoietic Cells From Human Embryonic Stem Cells. (2012) (0)
Pluripoietin a: A second human hematopoietic colony-stimulating (2003) (0)
PROSTAGLANDINS IN HUMAN TISSUES : THEIR IMPLICATION IN CANCER, HYPERCALCEMIA AND CELLULAR REGULATION (1983) (0)
Abstract 1528: Tunneling Nanotubes: a new approach to studying intercellular communication in aggressive solid tumor malignancies. (2013) (0)
SEPARATION OF MURINE MONONUCLEAR PHAGOCYTES BY VELOCITY SEDIMENTATION AT UNIT GRAVITY (1981) (0)
HEMATOPOIESIS AND STEM CELLS Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL 4-mediated degradation of HOXB 4 (2013) (0)
Post-Mortem Estate Planning (1984) (0)
Schematic diagram of IRES-based and dual promoter lentiviral vectors. (2014) (0)
Titelbild: At Last: Erythropoietin as a Single Glycoform (Angew. Chem. 46/2012) (2012) (0)
Generation of Human T/NK Cell Precursors for Adoptive Transfer To Enhance Immune Reconstitution in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Malcolm A. S. Moore?

Malcolm A. S. Moore is affiliated with the following schools: